argenx SE - Special Call Transcript
Okay. I think we're going to get started. Welcome to the argenx R&D Day. My name is Beth DelGiacco; I'm the Vice President of Investor Relations at argenx. And we've a very exciting program today, so I'm going to cut right to it. But first, we just have a few legal matters. We're going to be making forward-looking statements today. Please refer to the filings on our website to remind yourself of those risk factors. Today, we hope to convey a theme of growth and transformation. We held our first R&D Day in September 2016 right before our NASDAQ IPO. It was actually at this hotel in a different room. We have some consistent basis here, but I can tell you that the room is much more crowded today. So first, thank you for being here, and thank you for your ongoing support. You're going to hear today from 2 of our co-founders, Tim Van Hauwermeiren, our Chief Executive Officer; and Hans De Haard, our Chief Scientific Officer. You're also going to hear from our newest member of management, our incoming Chief Medical Officer, Wim Parys, who's going to talk about our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
